Compounds > ibuprofen, (r)-isomer
Page last updated: 2024-09-02

ibuprofen, (r)-isomer and mycophenolic acid

ibuprofen, (r)-isomer has been researched along with mycophenolic acid in 2 studies

Compound Research Comparison

Studies
(ibuprofen, (r)-isomer)		Trials
(ibuprofen, (r)-isomer)		Recent Studies (post-2010)
(ibuprofen, (r)-isomer)		Studies
(mycophenolic acid)		Trials
(mycophenolic acid)		Recent Studies (post-2010) (mycophenolic acid)
10049,0291,5063,772

Protein Interaction Comparison

ProteinTaxonomyibuprofen, (r)-isomer (IC50)mycophenolic acid (IC50)
Inosine-5'-monophosphate dehydrogenase 2Homo sapiens (human)0.1496
Glutamate receptor 1Rattus norvegicus (Norway rat)0.014
Glutamate receptor 2Rattus norvegicus (Norway rat)0.014
Glutamate receptor 3Rattus norvegicus (Norway rat)0.014
Glutamate receptor 4Rattus norvegicus (Norway rat)0.014
Inosine-5'-monophosphate dehydrogenase 1 Homo sapiens (human)0.0772
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.011
Inosine-5'-monophosphate dehydrogenaseCryptococcus neoformans var. neoformans JEC210.12

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Andricopulo, AD; Moda, TL; Montanari, CA1

Reviews

1 review(s) available for ibuprofen, (r)-isomer and mycophenolic acid

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

1 other study(ies) available for ibuprofen, (r)-isomer and mycophenolic acid

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007